BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2020. The put-call ratio across all filers is 4.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $894,418 | -28.1% | 17,810 | -9.6% | 0.05% | -24.6% |
| Q2 2023 | $1,244,661 | +36.1% | 19,694 | -3.1% | 0.06% | +32.6% |
| Q1 2023 | $914,692 | -2.8% | 20,331 | -5.4% | 0.05% | -6.1% |
| Q4 2022 | $941,477 | +13.0% | 21,490 | +70.0% | 0.05% | +4.3% |
| Q3 2022 | $833,000 | +30.0% | 12,644 | -0.3% | 0.05% | +46.9% |
| Q2 2022 | $641,000 | -19.0% | 12,685 | +2.5% | 0.03% | -11.1% |
| Q1 2022 | $791,000 | -39.9% | 12,376 | +0.7% | 0.04% | -36.8% |
| Q4 2021 | $1,316,000 | -33.6% | 12,291 | -36.2% | 0.06% | -36.7% |
| Q3 2021 | $1,981,000 | +3.0% | 19,267 | -11.9% | 0.09% | +5.9% |
| Q2 2021 | $1,924,000 | +6.5% | 21,868 | +17.7% | 0.08% | +2.4% |
| Q1 2021 | $1,806,000 | +7.8% | 18,576 | +24.3% | 0.08% | 0.0% |
| Q4 2020 | $1,676,000 | -3.0% | 14,946 | -19.8% | 0.08% | -11.7% |
| Q3 2020 | $1,728,000 | +12.5% | 18,645 | -5.3% | 0.09% | +13.3% |
| Q2 2020 | $1,536,000 | – | 19,692 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |